Patents/Assignees

BOUNDLESS BIO, Inc.

5 patents in portfolio

US12527790utility2026
Checkpoint Kinase 1 (CHK1) Inhibitors and Uses Thereof
0 cites
US12246017utility2025
Replication Stress Pathway Agent Compositions and Methods for Treating Cancer
0 cites
US11707462utility2023
Checkpoint Kinase 1 (CHK1) Inhibitors and Uses Thereof
0 cites
US11642345utility2023
Replication Stress Pathway Agent Compositions and Methods for Treating Cancer
0 cites
US11547711utility2023
Replication Stress Pathway Agent Compositions and Methods for Treating Cancer
0 cites